Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Giving Antiretroviral Drugs to Infants or Mothers Reduces Transmission of HIV Through Breast Milk
Giving daily antiretroviral syrup to breastfeeding infants or treating their HIV-infected mothers with highly active antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a study led by UNC-Chapel Hill investigators has found.
Located in Vital Signs / 2009 / Vital Signs - July 24, 2009
Hematologic malignancies rapidly increasing and unaddressed in sub-Saharan Africa
UNC-led team offers clinical, research agenda
Located in News / 2012 / April
HIV 101 provides comprehensive primer for new School of Medicine staff
The HIV and Clinical Trials 101 lecture series, which took place August 23-31, targets new research and clinical staff in the Division of Infectious Diseases and is an update on current practices related to HIV/AIDS.
Located in Vital Signs / 2010 / Sept. 30
HIV hides soon after infection, UNC research shows
A team of researchers led by the University of North Carolina School of Medicine has demonstrated that latency develops soon after infection and slows when antiretroviral therapy is given.
Located in News / 2012 / May
HIV Treatment Keeps Uninfected Partner from Contracting the Virus
Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission according to the groundbreaking study led by Myron Cohen, MD.
Located in News / 2016 / July
HIV/AIDS research and treatment timeline at UNC
The following timeline highlights events in HIV/AIDS research and treatment at the University of North Carolina and University of North Carolina Health Care System since 1981. Visit the link following each entry for more information.
Located in Vital Signs / 2011 / June 2
ID Conference: “Lessons from Botswana: Prevention and Treatment in the World’s Worst Epidemic of HIV/AIDS”
The presenter is Max Essex, DVM, PhD, Lasker Professor of Health Sciences at Harvard University, Chair of the Harvard School of Public Health AIDS Initiative, and Chair of the Botswana–Harvard AIDS Institute in Gaborone, Botswana.
Located in Vital Signs / 2012 / Sept. 27
Immune cells in the gut may improve control of HIV growth
A new study may help clarify why some people infected with HIV are better able to control the virus. It may also pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut.
Located in News / 2012 / June
Infectious Disease Clinic Celebrates Early Heroes
A recent gathering in the UNC Infectious Disease Clinic served as a reunion for the nurses and other medical staff who worked tirelessly to care for patients in the early days of the HIV/AIDS epidemic and ultimately led to the establishment of a dedicated clinic within the hospital for those patients.
Located in Vital Signs / 2016 / Jan. 7
Innate immune system can kill HIV when a viral gene is deactivated
Study published in PLoS Pathogens suggests new target for treatment and the eventual cure of HIV/AIDS
Located in News / 2013 / March